rs9332801
Variant names:
Variant summary
Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001197104.2(KMT2A):c.4284A>C(p.Ile1428Ile) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0571 in 1,613,484 control chromosomes in the GnomAD database, including 2,973 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.042 ( 185 hom., cov: 32)
Exomes 𝑓: 0.059 ( 2788 hom. )
Consequence
KMT2A
NM_001197104.2 synonymous
NM_001197104.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 1.77
Publications
17 publications found
Genes affected
KMT2A (HGNC:7132): (lysine methyltransferase 2A) This gene encodes a transcriptional coactivator that plays an essential role in regulating gene expression during early development and hematopoiesis. The encoded protein contains multiple conserved functional domains. One of these domains, the SET domain, is responsible for its histone H3 lysine 4 (H3K4) methyltransferase activity which mediates chromatin modifications associated with epigenetic transcriptional activation. This protein is processed by the enzyme Taspase 1 into two fragments, MLL-C and MLL-N. These fragments reassociate and further assemble into different multiprotein complexes that regulate the transcription of specific target genes, including many of the HOX genes. Multiple chromosomal translocations involving this gene are the cause of certain acute lymphoid leukemias and acute myeloid leukemias. Alternate splicing results in multiple transcript variants.[provided by RefSeq, Oct 2010]
KMT2A Gene-Disease associations (from GenCC):
- Wiedemann-Steiner syndromeInheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: G2P, Orphanet, Illumina, Labcorp Genetics (formerly Invitae), ClinGen
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.51).
BP6
Variant 11-118484927-A-C is Benign according to our data. Variant chr11-118484927-A-C is described in ClinVar as Benign. ClinVar VariationId is 158702.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=1.77 with no splicing effect.
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.0622 is higher than 0.05.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| KMT2A | NM_001197104.2 | c.4284A>C | p.Ile1428Ile | synonymous_variant | Exon 10 of 36 | ENST00000534358.8 | NP_001184033.1 |
Ensembl
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
|---|---|---|---|---|---|---|---|---|---|---|
| KMT2A | ENST00000534358.8 | c.4284A>C | p.Ile1428Ile | synonymous_variant | Exon 10 of 36 | 1 | NM_001197104.2 | ENSP00000436786.2 |
Frequencies
GnomAD3 genomes AF: 0.0415 AC: 6321AN: 152174Hom.: 185 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
6321
AN:
152174
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD2 exomes AF: 0.0500 AC: 12569AN: 251238 AF XY: 0.0532 show subpopulations
GnomAD2 exomes
AF:
AC:
12569
AN:
251238
AF XY:
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0588 AC: 85866AN: 1461192Hom.: 2788 Cov.: 30 AF XY: 0.0598 AC XY: 43453AN XY: 726904 show subpopulations
GnomAD4 exome
AF:
AC:
85866
AN:
1461192
Hom.:
Cov.:
30
AF XY:
AC XY:
43453
AN XY:
726904
show subpopulations
African (AFR)
AF:
AC:
289
AN:
33472
American (AMR)
AF:
AC:
1023
AN:
44690
Ashkenazi Jewish (ASJ)
AF:
AC:
1414
AN:
26126
East Asian (EAS)
AF:
AC:
1860
AN:
39674
South Asian (SAS)
AF:
AC:
6577
AN:
86190
European-Finnish (FIN)
AF:
AC:
3496
AN:
53416
Middle Eastern (MID)
AF:
AC:
295
AN:
5764
European-Non Finnish (NFE)
AF:
AC:
67593
AN:
1111498
Other (OTH)
AF:
AC:
3319
AN:
60362
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
3807
7614
11421
15228
19035
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
0
2530
5060
7590
10120
12650
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome AF: 0.0415 AC: 6321AN: 152292Hom.: 185 Cov.: 32 AF XY: 0.0426 AC XY: 3169AN XY: 74462 show subpopulations
GnomAD4 genome
AF:
AC:
6321
AN:
152292
Hom.:
Cov.:
32
AF XY:
AC XY:
3169
AN XY:
74462
show subpopulations
African (AFR)
AF:
AC:
420
AN:
41582
American (AMR)
AF:
AC:
389
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
AC:
164
AN:
3472
East Asian (EAS)
AF:
AC:
162
AN:
5186
South Asian (SAS)
AF:
AC:
329
AN:
4818
European-Finnish (FIN)
AF:
AC:
866
AN:
10600
Middle Eastern (MID)
AF:
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
AC:
3907
AN:
68022
Other (OTH)
AF:
AC:
74
AN:
2116
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.505
Heterozygous variant carriers
0
320
641
961
1282
1602
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
78
156
234
312
390
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
150
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Benign:4
-
Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC)
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Nov 19, 2013
Genetic Services Laboratory, University of Chicago
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
not provided Benign:3
Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Aug 10, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.